Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 15 (2024)
      • Volume 15 – Issue 1
      • Volume 15 – Issue 2
      • Volume 15 – Suppl. 1
    • VOLUME 14 (2023)
      • Volume 14 – Issue 3
      • Volume 14 – Issue 2
      • Volume 14 – Issue 1
      • Volume 14 – Suppl. 1
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: lipoproteins

Lipid markers, gender and cardiovascular disease; Highlights from the ATTICA prospective epidemiological study (2002-2012)

Matina Kouvari, Demosthenes B. Panagiotakos, Christina Chrysohoou, Ekavi N. Georgousopoulou, Dimitrios Tousoulis, Christos Pitsavos, The ATTICA study Investigators

Pharmacological management of nonalcoholic fatty liver disease: Limitations, challenges and new therapeutic opportunities

Eleni A. Karavia, Kyriakos E. Kypreos

Lipid control in patients with and without type 2 Diabetes Mellitus (T2DM). The experience of a special unit of a second grade hospital

Stamatis S Papadatos, Adamantios Bourdakis

HDL as a transporter of microRNAs in plasma: potential pathophysiolocal role

A. I. Gatsiou, K. Stellos, A. D. Tselepis

CURRENT ISSUE

Abdominal Aortic KLF4 Expression in Hyperlipidemic Rabbits: Impact of Colchicine Regimens
Non-alcoholic fatty liver disease and cardiovascular disease; from epidemiology to clinical and nutrition management: A narrative review

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (5) cardiovascular disease (28) cardiovascular diseases (6) Cardiovascular risk (6) childhood obesity (3) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (5) diabetes mellitus (9) diet (6) dyslipidemia (14) epidemiology (4) ezetimibe (5) Familial hypercholesterolemia (5) glucose (3) Heart failure (5) hypertension (9) inflammation (10) Ischemic stroke (3) lipoproteins (4) low-density lipoprotein cholesterol (3) Mediterranean diet (8) metabolic syndrome (7) morbidity (3) mortality (8) non-alcoholic fatty-liver disease (5) nonalcoholic fatty liver disease (3) obesity (9) omega-3 fatty acids (3) outcome (3) PCSK9 (3) PCSK9 inhibitors (5) physical activity (4) platelets (8) risk factors (3) smoking (3) statins (15) thrombosis (4) treatment (6) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2025
A SiteOrigin Theme